ClinicalTrials.gg
Not yet recruitingNCT07889141Exercises progUpdated Oct 22, 2026

Integrated Core Stability Exercises and Yoga Program on Premenstrual Syndrome

An interventional study of exercises program in Premenstrual Syndrome Symptoms and Quality of Life, sponsored by Mansoura University. Not yet recruiting at 2 sites in Egypt. Open to female participants aged 15 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
92
Allocation
Randomized
Ages
15 Years to 25 Years
Sex
Female
01

Study summary

This study aims to evaluate the effect of an integrated yoga and core stability exercises program on the severity of premenstrual syndrome symptoms and quality of life among nursing students.

Read the detailed description

Premenstrual syndrome (PMS) is a common health problem that affects women during the reproductive age. It is a menstrual disorder characterized by a cluster of physical, psychological and behavioral symptoms that manifest cyclically during the luteal phase of the menstrual cycle and resolve rapidly within a few days of the onset of menstruation.

University students are the most vulnerable group to the severe form of PMS due to poor sleep quality, unorganized dietary habits, high caffeine consumption, and chronic academic stress.

Management of PMS usually includes both pharmacological and nonpharmacological modalities. Pharmacological interventions typically serve as the first line of defense for severe presentations. Physical exercise is one of the non-pharmacological interventions for management of PMS that is safe, highly effective and inexpensive. Regular physical activity stimulates the release of beta-endorphins (natural analgesics), reduces circulating cortisol levels, improves systemic blood flow and downregulates inflammatory processes

02

Conditions studied

  • Premenstrual Syndrome Symptoms and Quality of Life

Keywords

  • Core Stability Exercises, Yoga, Premenstrual Syndrome Symptoms ,Quality of Life .
03

In context

Lead sponsor

Mansoura University is the lead sponsor of 1,114 studies on the registry; 185 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1. Aged 15- 25 years. 2. Have normal body mass index (20 - 29 kg/m2). 3. Have PMS symptoms that resolve within 4 days after the onset of menstruation and are present during ≥3 consecutive symptomatic cycles.

    4. Have at least 6 months of regular cycles (21-35 days and 4-7 days of blood flow).

    5. Have a smartphone with WhatsApp application.

Exclusion criteria

Exclusion Criteria:

  • 1. Presence of diabetes, mental and physical illness, or diagnosed psychological disorder.

    2. History of joint movement and muscle diseases, endometriosis, pregnancy or lactation period, smoking and alcohol use, polycystic ovary syndrome, or oral contraceptive and antidepressant use.

    3. Participating in other exercise programs, being a licensed athlete, or use vitamin-mineral or herbal supplement.

    4. Adolescent students who consume painkillers or herbal medicines during the intervention or perform other non-pharmacological interventions.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
92 participants (estimated)

Study arms

  • Experimental
    Exercise Program

    practicing an integrated yoga and core stability exercises program for 60 minutes, 3 times/week, for 8 weeks.

    Behavioral: exercises program

  • No intervention
    Control

    practice only the routine daily activities for 8 weeks

Interventions

  • Behavioralexercises program

    practice an integrated yoga and core stability exercises program for 60 minutes, 3 times/week, for 8 weeks.

06

What researchers measure

Primary outcomes

  1. Reduction in premenstrual syndrome symptoms severity

    Nursing students who practice in an integrated yoga and core stability exercises program experience reduction in premenstrual syndrome symptoms severity than nursing students who do not practice yoga and core stability exercises.

    Time frame: after 4 weeks , (follow up) after 8 weeks

07

Study locations

2 sites
  • Faculty of Nursing
    Al Mansurah, Dakahlia Governorate, Egypt
  • Faculty of Nursing
    Al Mansurah, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 22, 2026
StartEst.
Nov 10, 2026
Primary completionEst.
Jan 2027
CompletionEst.
Feb 2027
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07889141
Responsible party
Eman Hassan Ragab Elshrqawy (lecturer of women's Health & Midwifery Nursing Department, Mansoura University) — Principal investigator
First posted
Oct 22, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
Jan 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Oct 22, 2026

Study contacts

Elshrqawy Eman Elshrqawy, Lecturer
Contact
eman_hassan@mans.edu.eg
01554546002

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion